Repligen Corp (NASDAQ:RGEN)

40.38
Delayed Data
As of May 27
 -0.13 / -0.32%
Today’s Change
18.23
Today|||52-Week Range
42.43
+103.94%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close40.51
Today’s open40.54
Day’s range39.91 - 41.07
Volume310,608
Average volume (3 months)441,171
Market cap$1.3B
Dividend yield--
Data as of 4:14pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio197.8
Price/Sales10.13
Price/Book11.88

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.04+0.33%
ACORAcorda Therapeutics ...-0.12-0.38%
INSMInsmed Inc+0.23+1.04%
CLLSCellectis SA+4.54+12.46%
Data as of 4:00pm ET, 05/27/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers